PTC Therapeutics raises $50 million
This article was originally published in Scrip
Executive Summary
PTC Therapeutics of the US has completed a $50 million fundraising, its first syndicated equity financing round in more than four years. The round was led by new investor The Column Group and existing investor Delphi Ventures.